{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T09:08:02Z","timestamp":1784192882900,"version":"3.55.0"},"reference-count":29,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T00:00:00Z","timestamp":1781308800000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Department of Nephrology at Mainz University Medical Center"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background and hypothesis<\/jats:title>\n                    <jats:p>Platelet inhibitor therapy is a relative contraindication to percutaneous kidney biopsies due to concerns about bleeding risk. Here, we present an analysis of a prospective observational study on the risk of complications after native and transplant kidney biopsies with and without platelet inhibition.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this study, 1103 consecutive biopsies between 2020 and 2025 at a single tertiary academic care center were included (26.0% in transplanted kidneys). Complications after biopsy were assessed and recorded before discharge, which was the day after the biopsy unless complications occurred. The primary outcome was serious complications, defined as any unplanned procedures or prolongation of the hospital stay. Secondary outcomes included hematuria, hematoma, placement of a Foley catheter, arteriovenous fistula, X-ray imaging, radiological intervention to stop bleeding, and transfusion. Bleeding was also classified according to the criteria of the International Society on Thrombosis and Hemostasis and Bleeding Academic Research Consortium.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of total biopsies, 43.0% were performed in women, and 13.0% with continued platelet inhibition. Serious complications occurred in 4.3% of cases: native kidney biopsies, 5.0% versus transplant biopsies, 2.1% (log odds ratio, \u22120.91; 95% confidence interval, \u22121.9 to \u22120.11; P\u00a0=\u00a0.040). Transfusion was required in 1.8% of cases. Female sex, right-lateral position, and native kidney biopsy were associated with complications. In multivariable logistic regression analysis, platelet inhibition was not associated with increased risk of serious complications (log odds ratio, \u22120.23; 95% confidence interval, \u22121.7 to 0.87; P\u00a0=\u00a0.7). The risk of transfusion was associated with low hemoglobin before biopsy, hematuria before biopsy, and biopsies performed with the patient sitting, but not platelet inhibition in multivariable regression. No patient died of a complication.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Platelet inhibition is not statistically associated with increased risk of serious complications after kidney biopsy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ndt\/gfag139","type":"journal-article","created":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T16:07:19Z","timestamp":1781453239000},"source":"Crossref","is-referenced-by-count":0,"title":["Bleeding risk after kidney biopsy with platelet inhibition"],"prefix":"10.1093","author":[{"given":"Daniel","family":"Kraus","sequence":"first","affiliation":[{"name":"Department of Medicine \u2013 Nephrology, Rheumatology, and Kidney Transplantation, Johannes Gutenberg University Medical Center , Mainz 55131 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Razan","family":"Sadek","sequence":"additional","affiliation":[{"name":"Department of Medicine \u2013 Nephrology, Rheumatology, and Kidney Transplantation, Johannes Gutenberg University Medical Center , Mainz 55131 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Kommer","sequence":"additional","affiliation":[{"name":"Department of Medicine \u2013 Nephrology, Rheumatology, and Kidney Transplantation, Johannes Gutenberg University Medical Center , Mainz 55131 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Cla\u00dfen","sequence":"additional","affiliation":[{"name":"Department of Medicine \u2013 Nephrology, Rheumatology, and Kidney Transplantation, Johannes Gutenberg University Medical Center , Mainz 55131 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Stortz","sequence":"additional","affiliation":[{"name":"Department of Medicine \u2013 Nephrology, Rheumatology, and Kidney Transplantation, Johannes Gutenberg University Medical Center , Mainz 55131 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Holtz","sequence":"additional","affiliation":[{"name":"Department of Medicine \u2013 Nephrology, Rheumatology, and Kidney Transplantation, Johannes Gutenberg University Medical Center , Mainz 55131 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Weber","sequence":"additional","affiliation":[{"name":"Department of Medicine \u2013 Nephrology, Rheumatology, and Kidney Transplantation, Johannes Gutenberg University Medical Center , Mainz 55131 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7344-8381","authenticated-orcid":false,"given":"Julia","family":"Weinmann-Menke","sequence":"additional","affiliation":[{"name":"Department of Medicine \u2013 Nephrology, Rheumatology, and Kidney Transplantation, Johannes Gutenberg University Medical Center , Mainz 55131 ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,6,13]]},"reference":[{"key":"2026071605012455500_bib1","doi-asserted-by":"publisher","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","article-title":"KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease","volume":"105","author":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group","year":"2024","journal-title":"Kidney Int"},{"key":"2026071605012455500_bib2","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1093\/ckj\/sfy075","article-title":"Renal biopsy: it is time for pragmatism and consensus","volume":"11","author":"Lees","year":"2018","journal-title":"Clin Kidney J"},{"key":"2026071605012455500_bib3","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1093\/ndt\/gfac177","article-title":"The risks associated with percutaneous native kidney biopsies: a prospective study","volume":"38","author":"Andrulli","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"2026071605012455500_bib4","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.2215\/CJN.14721219","article-title":"Major bleeding and risk of death after percutaneous native kidney biopsies: a French nationwide cohort study","volume":"15","author":"Halimi","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026071605012455500_bib5","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1093\/ckj\/sfx012","article-title":"Risk factors for bleeding complications after nephrologist-performed native renal biopsy","volume":"10","author":"Lees","year":"2017","journal-title":"Clin Kidney J"},{"key":"2026071605012455500_bib6","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.jvir.2016.10.021","article-title":"Effects of aspirin therapy on ultrasound-guided renal allograft biopsy bleeding complications","volume":"28","author":"Baffour","year":"2017","journal-title":"J Vasc Interv Radiol"},{"key":"2026071605012455500_bib7","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s40620-022-01441-7","article-title":"Risk of bleeding after percutaneous native kidney biopsy in patients receiving low-dose aspirin: a single-center retrospective study","volume":"36","author":"Fontana","year":"2023","journal-title":"J Nephrol"},{"key":"2026071605012455500_bib8","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1053\/j.ajkd.2012.02.330","article-title":"Bleeding complications of native kidney biopsy: a systematic review and meta-analysis","volume":"60","author":"Corapi","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"2026071605012455500_bib9","doi-asserted-by":"publisher","first-page":"67","DOI":"10.5414\/CN109274","article-title":"Risk of complications with use of aspirin during renal biopsy: a systematic review","volume":"89","author":"Kumar","year":"2018","journal-title":"Clin Nephrol"},{"key":"2026071605012455500_bib10","first-page":"700","article-title":"Effects of aspirin on kidney biopsy bleeding complications: a systematic review and meta-analysis (PROSPERO 2021 CRD42021261005)","volume":"4","author":"Relvas","year":"2023","journal-title":"Kidney360"},{"key":"2026071605012455500_bib11","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"Schulman","year":"2005","journal-title":"J Thromb Haemost"},{"key":"2026071605012455500_bib12","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1161\/CIRCULATIONAHA.110.009449","article-title":"Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium","volume":"123","author":"Mehran","year":"2011","journal-title":"Circulation"},{"key":"2026071605012455500_bib13","volume-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team."},{"key":"2026071605012455500_bib14","volume-title":"cowplot: Streamlined Plot Theme and Plot Annotations for \u201cggplot2\u201d.","author":"Wilke CO"},{"key":"2026071605012455500_bib15","volume-title":"DescTools: Tools for Descriptive Statistics","author":"Signorell"},{"key":"2026071605012455500_bib16","doi-asserted-by":"publisher","first-page":"570","DOI":"10.32614\/RJ-2021-053","article-title":"Reproducible summary tables with the gtsummary package","volume":"13","author":"Sjoberg","year":"2021","journal-title":"The R Journal"},{"key":"2026071605012455500_bib17","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1159\/000351043","article-title":"Estimating the glomerular filtration rate in the general population using different equations: effects on classification and association","volume":"123","author":"Pattaro","year":"2013","journal-title":"Nephron Clin Pract"},{"key":"2026071605012455500_bib18","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.21105\/joss.01686","article-title":"Welcome to the tidyverse","volume":"4","author":"Wickham","year":"2019","journal-title":"J Open Source Softw"},{"key":"2026071605012455500_bib19","doi-asserted-by":"publisher","first-page":"3566","DOI":"10.1093\/ndt\/gfn282","article-title":"Is it necessary to stop antiplatelet agents before a native renal biopsy?","volume":"23","author":"Mackinnon","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"2026071605012455500_bib20","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.2215\/CJN.04710420","article-title":"Systematic review and meta-analysis of native kidney biopsy complications","volume":"15","author":"Poggio","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"key":"2026071605012455500_bib21","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1093\/ckj\/sfx102","article-title":"Trends and outcomes of the use of percutaneous native kidney biopsy in the United States: 5-year data analysis of the Nationwide Inpatient Sample","volume":"11","author":"Al\u00a0Turk","year":"2018","journal-title":"Clin Kidney J"},{"key":"2026071605012455500_bib22","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1093\/ckj\/sfz132","article-title":"Clinical parameters predicting complications in native kidney biopsies","volume":"13","author":"Peters","year":"2020","journal-title":"Clin Kidney J"},{"key":"2026071605012455500_bib23","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1159\/000503255","article-title":"Outpatient kidney biopsy: a single center experience and review of literature","volume":"144","author":"Aaltonen","year":"2020","journal-title":"Nephron"},{"key":"2026071605012455500_bib24","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.ekir.2020.01.012","article-title":"Bleeding complications after percutaneous native kidney biopsy: results from the Boston Kidney Biopsy Cohort","volume":"5","author":"Palsson","year":"2020","journal-title":"Kidney Int Rep"},{"key":"2026071605012455500_bib25","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1111\/j.1523-1755.2004.00922.x","article-title":"Predictors of bleeding complications in percutaneous ultrasound-guided renal biopsy","volume":"66","author":"Manno","year":"2004","journal-title":"Kidney Int"},{"key":"2026071605012455500_bib26","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1007\/s00261-019-01962-z","article-title":"Risk factors associated with significant bleeding events after ultrasound-guided percutaneous native renal biopsies: a review of 2204 cases","volume":"44","author":"Monahan","year":"2019","journal-title":"Abdom Radiol"},{"key":"2026071605012455500_bib27","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1159\/000477453","article-title":"Arterial stiffness is an independent risk factor for anemia after percutaneous native kidney biopsy","volume":"42","author":"Tanaka","year":"2017","journal-title":"Kidney Blood Press Res"},{"key":"2026071605012455500_bib28","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0272-6386(96)90129-8","article-title":"Timing of complications in percutaneous renal biopsy: what is the optimal period of observation?","volume":"28","author":"Marwah","year":"1996","journal-title":"Am J Kidney Dis"},{"key":"2026071605012455500_bib29","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1097\/01.ASN.0000102472.37947.14","article-title":"Timing of complications in percutaneous renal biopsy","volume":"15","author":"Whittier","year":"2004","journal-title":"J Am Soc Nephrol"}],"container-title":["Nephrology Dialysis Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ndt\/advance-article-pdf\/doi\/10.1093\/ndt\/gfag139\/68523122\/gfag139.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ndt\/advance-article-pdf\/doi\/10.1093\/ndt\/gfag139\/68523122\/gfag139.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T09:01:41Z","timestamp":1784192501000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ndt\/advance-article\/doi\/10.1093\/ndt\/gfag139\/8707698"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,13]]},"references-count":29,"URL":"https:\/\/doi.org\/10.1093\/ndt\/gfag139","relation":{},"ISSN":["0931-0509","1460-2385"],"issn-type":[{"value":"0931-0509","type":"print"},{"value":"1460-2385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,13]]},"article-number":"gfag139"}}